Optimal Pancreatic Surgery: Are We Making Progress in North America?

Joal D. Beane, MD; Jeffrey D. Borrebach, MS; Amer H. Zureikat, MD; E. Molly Kilbane, RN; Vanessa M. Thompson, PhD; Henry A. Pitt, MD


Annals of Surgery. 2021;274(4):e355-e363. 

In This Article


In conclusion, preoperative, intraoperative, and postoperative pancreatic surgery processes have evolved in North America from 2013 to 2017. During this period, more patients received neoadjuvant therapy, operative time, and transfusions reduced, and drain management changed. For PD, reductions of postoperative overall morbidity and need for percutaneous drainage, and also reduced LOS led to an increase in optimal pancreatic surgery from 54% to 57% (adjusted odds 1.058, P < 0.001). For DP, reduced need for postoperative percutaneous drainage and shorter LOS resulted in an increase in the percentage of patients achieving optimal pancreatic surgery from 53% to 59% (adjusted odds 1.085, P < 0.001). This analysis suggests that progress has been made for North American patients undergoing pancreatic surgery.